Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

On June 23, 2026, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) revealed its inclusion in an editorial released by BioMedWire (BMW). This publication was part of the Dynamic Brand Portfolio @ IBN, a specialized platform under the InvestorBrandNetwork. This network comprises over 75 brands and primarily deals with financial news and content distribution for both private and public companies, catering to the investment community.